Prednisolone, Trimeprazine Tartrate

Verify with FDA CVM →

78 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
78
Total Reports
10
Deaths Reported
1280.0%
Death Rate

Active Ingredients

Prednisolone, Trimeprazine Tartrate

Administration Routes

OralUnknown

Species Affected

Dog 69
Unknown 6
Human 2
Cat 1

Most Affected Breeds

Crossbred Canine/dog 10
Unknown 8
Retriever - Labrador 7
Pug 3
Spitz - German Pomeranian 3
Terrier - Jack Russell 3
Spaniel - Cocker American 3
Chihuahua 3
Poodle (unspecified) 3
Retriever - Golden 3

Most Reported Reactions

Vomiting 17
Anorexia 12
Depression 12
Diarrhoea 10
Anaemia NOS 8
Polyuria 8
Elevated serum alkaline phosphatase (SAP) 7
Polydipsia 6
Convulsion 6
Death 5
Elevated alanine aminotransferase (ALT) 5
Bloody diarrhoea 5

Outcome Breakdown

Died
10 (100.0%)

Data Summary

Metric Value
Total adverse event reports 78
Reports involving death 10
Case-fatality rate (reported events) 1280.0%
Distinct species in reports 4
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Prednisolone, Trimeprazine Tartrate Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 78 adverse event reports referencing Prednisolone, Trimeprazine Tartrate, including 10 reports in which the animal died — a 1280.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Prednisolone, Trimeprazine Tartrate. Reported administration routes include Oral, Unknown. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Prednisolone, Trimeprazine Tartrate reports are Dog (69 reports), Unknown (6 reports), Human (2 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (10), Unknown (8), Retriever - Labrador (7) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Prednisolone, Trimeprazine Tartrate are Vomiting (17), Anorexia (12), Depression (12), Diarrhoea (10). Of the 10 reports with a coded outcome, Died is the leading category at 100.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Prednisolone, Trimeprazine Tartrate.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial